Skip to content

Effect of topical Tranexamic Acid on management of gastrointestinal bleeding

Assessment of effect of topical Tranexamic Acid on management of acute upper gastrointestinal bleeding in patients presented to emergency department

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201201148721N1
Enrollment
130
Registered
2012-11-06
Start date
2012-02-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper Gastrointestinal Bleeding. Acute haemorrhagic gastritis

Interventions

Intervention 1: Interventio group: In addition to conventional therapy, we add 1 gram tranexamic acid, diluted into 500cc normal saline, to gastric washing fluid. we used Tranexamic Acid Ampule manifa
Treatment - Drugs
Interventio group: In addition to conventional therapy, we add 1 gram tranexamic acid, diluted into 500cc normal saline, to gastric washing fluid. we used Tranexamic Acid Ampule manifactured by Caspia
Control group: In addition to conventional therapy, we add free water (similar to tranexamic acid ampule) to fliud water for gastric washing.

Sponsors

Private Resiurces (Attending and Resident of incharge)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion Criteria: Symptoms or signs of GI bleeding. Exclusion Criteria: Pregnancy; Lactation; Gastrointestinal Malignancy; Coagulopathy; History of Thromboembolism; History of myocardial infarction or ischemic cerebrovascular accident; End Stage Renal Disease; Allergy to TA; Undergoing anticoagulation therapy; Congenital or acquired coagulopathy; who were reluctant to enroll in this study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Packed RBC. Timepoint: from intervention to discharge. Method of measurement: patient hospital document.

Secondary

MeasureTime frame
30-day Mortality. Timepoint: From intervantion to 1 month later. Method of measurement: Patients' Hospital Document and Phone Contact.;Tranexamic Acid Complication. Timepoint: during the study. Method of measurement: According to clinical manifestation, physical examination and doppler sonography.;Re-bleeding. Timepoint: From intervention to Discharge. Method of measurement: Patients' Hospital Document.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahdi Rezai

Tehran University of Medical Sciences

rezaei-m@razi.tums.ac.ir ; mah_re@yahoo.com+98 21 8868 1103

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026